The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAGIO THERAPEUTICS INC | COM | 00534A102 | 29,176 | 6,398,250 | SH | SOLE | 6,398,250 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 3,617 | 389,353 | SH | SOLE | 389,353 | 0 | 0 | ||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 4,732 | 466,200 | SH | SOLE | 466,200 | 0 | 0 | ||
| CURIS INC | COM NEW | 231269200 | 10,099 | 4,243,293 | SH | SOLE | 4,243,293 | 0 | 0 | ||
| LEAP THERAPEUTICS INC | COM | 52187K101 | 4,663 | 2,664,400 | SH | SOLE | 2,664,400 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 6,816 | 82,900 | SH | SOLE | 82,900 | 0 | 0 | ||
| NEXIMMUNE INC | COM | 65344D109 | 562 | 133,442 | SH | SOLE | 133,442 | 0 | 0 | ||
| PROQR THERAPEUTICS N V | SHS EURO | N71542109 | 907 | 1,001,800 | SH | SOLE | 1,001,800 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 11,354 | 715,880 | SH | SOLE | 715,880 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 11,097 | 527,150 | SH | SOLE | 527,150 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 9,966 | 1,047,900 | SH | SOLE | 1,047,900 | 0 | 0 | ||
| VERVE THERAPEUTICS INC | COM | 92539P101 | 4,073 | 178,500 | SH | SOLE | 178,500 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 11,700 | 5,850,000 | SH | SOLE | 5,850,000 | 0 | 0 | ||